Overview

Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate the efficacy and safety of a grass sublingual tablet in children and adolescents with a history of grass-pollen induced rhinoconjunctivitis with or without asthma.
Phase:
Phase 3
Details
Lead Sponsor:
ALK-Abelló A/S
Merck Sharp & Dohme Corp.
Treatments:
Albuterol
Fluticasone
Loratadine
Mometasone Furoate
Olopatadine Hydrochloride
Prednisone